Denver, CO, November 08, 2019 --(PR.com
)-- Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (USAF) has awarded the Company a $750,000 Small Business Innovation Research (SBIR) Phase II contract under Special Topics in the 19.1 Cycle through AFLMC and AFRL. Under this contract, Securisyn will prototype and refine an endotracheal tube securement device based on the Company’s proprietary interlocking restraint system (IRS) technology, the SolidAIRity™ III Airway Stabilization System. This prototype device will be optimized to meet the unique challenges and austere environments of pre-hospital providers in the Air Force medical community.
“The Air Force continues to drive innovation through the SBIR program and especially the open topics focus areas,” said Greg Letendre, Securisyn’s VP of Business Development for the Federal Sector and a USAFA graduate and Air Force officer. “Our company is excited to continue this path with the Air Force as we innovate a device critical to survival of our warfighters as well as civilian patients. Our contract award to make a better endotracheal tube securement device for the pre-hospital phases of care is a testament to the Air Force’s focus on solving important issues that severely impact patient safety in the military and civilian environments. With Air Force funding we will be able to make a better device to reduce the possibility of unplanned extubation and thereby prevent the needless loss of lives.”
Mark Bruning, Securisyn’s President and CEO, added, “This Air Force SBIR contract, our third such award, speaks to the Air Force’s continuing belief that our advancement in medical technologies can play a direct role in saving countless lives, to include America’s warriors on the battlefield. We are extremely grateful to the Air Force and specifically, Colonel Dale White and the ISR & SOF directorate that first saw the promise of our solution and supported the initial research and development necessary to better understand and serve their needs. Our work under this contract will drive better outcomes for both warfighters and civilian patients in pre-hospital phases of care.”
This innovative US Air Force SBIR program, Special Topics, AF191-010, was developed by the Air Force to increase the efficiency, effectiveness, and transition rate of the SBIR program. Several previous barriers to working with the Air Force have been removed or mitigated in this program, to include a shorter application process, an accelerated contract award, and a shorter period of performance. The Air Force heralds the SBIR program to “...do business at the speed of ideas by inspiring and accelerating startup and small business creativity.”
SolidAIRity™ uses a patented interlocking restraint system to secure a patient’s life-sustaining endotracheal tube and protect the patient from harm through accidental movement or worse -- removal of the tube. Patients are at the greatest risk during transport or when other external forces come in contact with the tube. Current methods used by medical providers to secure the endotracheal tube are inadequate and cannot prevent accidental removal against these external forces. Providers are often faced with the options of adhesives or sutures to try to hold onto a slippery, plastic tube surface.
Securisyn Medical intends to use its lifesaving technology to fill this unmet need for civilian and military healthcare facilities globally that deliver care to patients and rely on endotracheal tubes to secure the patient’s airway. These patients in critical care areas such as Intensive Care Units (ICU), Operating Rooms (OR) and Emergency Departments (ED), as well as ground and air medical transportation entities.
About Securisyn Medical, LLC
Securisyn Medical, LLC (www.securisyn.com) headquartered in Highlands Ranch, Colorado, is an innovative medical technology and solutions company dedicated to creating and cultivating an approach to airway management that will enhance airway safety, prevent unplanned extubation and its associated complications, provide peace of mind for patients, their families, and practitioners and decrease healthcare costs through ethical, profitable, and sustainable business practices. The company is focused on collaborating with stakeholders around the world to eliminate preventable deaths related to airway management.